# The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19

> **NCT04891250** · PHASE4 · WITHDRAWN · sponsor: **Centre for Infectious Disease Research in Zambia**

## Conditions studied

- SARS-CoV-2
- Ivermectin

## Interventions

- **DRUG:** Ivermectin
- **OTHER:** Prophylaxis

## Key facts

- **NCT ID:** NCT04891250
- **Lead sponsor:** Centre for Infectious Disease Research in Zambia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-10
- **Primary completion:** 2021-12
- **Final completion:** 2022-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient funding
- **Last updated:** 2022-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04891250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04891250, "The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04891250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*